Victoria Kyrychenko

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Google:
"Victoria Kyrychenko"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang QJ, Tran TAT, Wang M, et al. (2018) Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis. Nature Communications. 9: 5230
Long C, Li H, Tiburcy M, et al. (2018) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Science Advances. 4: eaap9004
Parra VM, Altamirano F, Hernández-Fuentes CP, et al. (2018) Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network. Circulation Research
Kang C, Badr MA, Kyrychenko V, et al. (2017) Deficit in PINK1-PARKIN mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. Cardiovascular Research
Kyrychenko V, Kyrychenko S, Tiburcy M, et al. (2017) Functional correction of dystrophin actin binding domain mutations by genome editing. Jci Insight. 2
Gonzalez JP, Kyrychenko S, Kyrychenko V, et al. (2016) Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras. Stem Cells (Dayton, Ohio)
Morales CR, Li DL, Pedrozo Z, et al. (2016) Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Science Signaling. 9: ra34
Li DL, Wang ZV, Ding G, et al. (2016) Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. Circulation
Long C, Li H, Kyrychenko V, et al. (2016) 730. Permanent Correction of Diverse Muscular Dystrophy Mutations in Human Cardiomyocytes by Myoediting Molecular Therapy. 24: S288
Kyrychenko S, Kyrychenko V, Badr MA, et al. (2015) Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy. Cardiovascular Research
See more...